REPORT JUST DROPPED - Check this out!, page-16

2 New sets of Data to report today as we watch the share price get the usual 'walking down' as well as the usual radio silence.

First is the latest ASIC data for trading on last Thursday 8th May. 10 thousand new open short fake Sell liquidity shares sold on that single day alone which is rather amazing when the total volume that day was only 42 thousand with much of that being churn trades. So shorters desperate to stop any price rises at Clinuvel and always throwing in new fake shares to keep the share price where they want it. Nothing new with this manipulation, nearly every day closing the price near daily lows and well below VWAP and pushing especially hard to dampen sentiment whenever great new profits or other good news is released. Always amazing to me that the company keeps allowing 'those who would gamble against the company' to have total freedom in doing this despite very strong statements about 'striking' on shareholder behalf via a 1.5 Million share buyback. This total lack of buyback, directly the opposite of what Clinuvel said, is absolutely bewildering and I certainly wouldn't be surprised if some sort of action against them arises from what is going on in this regard. That would really be interesting if that hypothetical scenario arose, would they spend millions of shareholder cash to fight something that will only cost them less than 10% of the massive shareholder cash reserves if they just implemented it as stated while simultaneously bringing all the positives that come from buying back shares? Such a terrible effort of a share buyback, I have never heard of any other company promising so much and then delivering almost nothing in relation to a buyback as their shares continue to plummet despite producing ever increasing profits and growing cash to an incredible $200 Million not to mention other positive announcements. A simple capital distribution, received by investors with total positivity, has been turned into a farce by those responsible.

Second is closest comparison company Disc (with their mind boggling valuation 5 times greater than Clinuvel) just reported new financials which show they are burning cash at an ever increasing rate while trying to get their lead product with EPP approved (Q1 loss USD $34.1 Million up from last year Q1 $26.9 Million USD). Disc are losing about $1 Million AUD every two days compared to Clinuvel printing cash at an ever increasing rate. Approval in EPP would hardly be enough to turn those losses into profits IMO for Disc, especially when P2 trial results don't show any significant benefit for time in sunlight for EPP patients over a placebo. Nothing like blockbuster Vitiligo for Disc which Clinuvel is bringing closer every day to Phase 3 completion either. I think in the recent webinar after Clinuvel's excellent 1st half year results there was some very interesting commentary regarding Disc (and MT) by LH."Both of the two active companies are yet to complete clinical studies and generate data that would satisfy a regulatory agency."This was in the Q&A section and there were more interesting points, but there is no wayDisc will never compete with Clinuvel in the blockbuster Vitiligo or Tanning Markets because their product simply can't do those things.

All IMO DYOR